Spyre Therapeutics, Inc. SYRE Earnings yield
Earnings yield at other companies
Other financials
Where this comes from
Calculated from Spyre Therapeutics, Inc.’s reported figures.
Based on trailing twelve months.
The official record: Spyre Therapeutics, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Spyre Therapeutics, Inc.'s earnings yield.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Spyre Therapeutics, Inc.'s earnings yield?
- Spyre Therapeutics, Inc. (SYRE) reported earnings yield of -4.5% in Q1 2026.
- How has Spyre Therapeutics, Inc.'s earnings yield changed year-over-year?
- Spyre Therapeutics, Inc.'s earnings yield increased by 78.9% year-over-year, from -21.5% to -4.5%.
- What is the long-term trend for Spyre Therapeutics, Inc.'s earnings yield?
- Over 5 years (2020 to 2025), Spyre Therapeutics, Inc.'s earnings yield has grown at a -20.5% compound annual growth rate (CAGR), from -19.3% to -6.1%.
- What does earnings yield mean?
- The company's annual profit as a percentage of its market price — the flip side of the P/E.
- How do you interpret earnings yield?
- Higher means more earnings per dollar invested. Easy to compare directly against bond yields to judge the relative attractiveness of equity.
- How does earnings yield compare across companies?
- Comparable across profitable companies and against fixed-income yields; undefined when earnings are negative.